A day after some media reports claimed that Covaxin’s maker, the Hyderabad-based Bharat Biotech, had cut corners to make the COVID-19 vaccine, the Union Health ministry on Thursday said the allegations are “completely misleading, fallacious and ill-informed”.
"It is well known that they helped perpetuate misinformation and fake news throughout the pandemic.
These trials have clearly demonstrated safety and efficacy of Covaxin.
The Ministry also categorically denied claims of media reports that had spoken about some 'unscientific changes' in the clinical trials of Covaxin. "
Moreover, the purported unscientific changes' in clinical trials of Covaxin, as claimed in the news reports, were made after submission made by Bharat Biotech in CDSCO, compliance of due process in CDSCO and with approval from the DGCI," the Ministry's statement read.
The Covaxin shot did not require storage at very low temperatures, which was easier to deploy in low- and middle-income countries.
Source: BusinessToday
#BharatBiotech